Ryan Allway June 14th, 2022 Psychedelics, Top News Vancouver, British Columbia–(Newsfile Corp. – June 14, 2022) – Lobe Sciences Ltd. (CSE: LOBE) (OTCQB: LOBED) (“Lobe” or the “Company”), a Canadian Biopharmaceutical Company committed to discovering and developing psychedelic inspired medicines for the improvement of neurologic, brain and mental health disorders is... Read more